TissUse grants first Smart Hair Transplant (SHT) License in Japan

For the first time, TissUse has granted development and distribution rights of its existing Smart Hair Transplant (SHT) technology to J. Hewitt, a Japan-based biopharmaceutical company focused on creating transformative regenerative medicine for aesthetic surgery. Under the terms of this agreement, TissUse grants J. Hewitt an exclusive license in Japan for the development of novel … „TissUse grants first Smart Hair Transplant (SHT) License in Japan“ weiterlesen

All4Labels: External Business Partner of the Year for “End2End Synchronization”

All4Labels – Global Packaging Group was awarded as External Business Partner of the Year for „End2End Synchronization“ by Procter & Gamble

All4Labels – Global Packaging Group was awarded as External Business Partner of the Year for „End2End Synchronization“ by Procter & Gamble

TissUse establishes a liver-endocrine tissues multi-organ model for risk assessment with Bayer

TissUse has signed a collaboration agreement with Bayer to develop a highly innovative liver-endocrine tissues assay using TissUse’s Multi-Organ-Chip (MOC) technology. Under the terms of the collaboration agreement, TissUse will join forces with Bayer to develop a novel mechanistic in vitro assay that will allow assessment of species differences of critical toxicities for early development … „TissUse establishes a liver-endocrine tissues multi-organ model for risk assessment with Bayer“ weiterlesen

TissUse announces new partnership with leading pharmaceutical company to develop applications for its Multi-Organ-Chip platform in drug research and development

TissUse and Roche have signed a cooperating agreement to develop human-relevant in vitro assays based on TissUse’s Multi-Organ-Chip technology. Under the terms of the collaboration agreement, TissUse will provide its Multi-Organ-Chip (MOC) technology as a highly versatile tool to develop in vitro assays to increase prediction of safety liabilities of drug candidates early on. During … „TissUse announces new partnership with leading pharmaceutical company to develop applications for its Multi-Organ-Chip platform in drug research and development“ weiterlesen